DK1224177T3 - Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner - Google Patents

Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner

Info

Publication number
DK1224177T3
DK1224177T3 DK00970988T DK00970988T DK1224177T3 DK 1224177 T3 DK1224177 T3 DK 1224177T3 DK 00970988 T DK00970988 T DK 00970988T DK 00970988 T DK00970988 T DK 00970988T DK 1224177 T3 DK1224177 T3 DK 1224177T3
Authority
DK
Denmark
Prior art keywords
preparation
oxazolines
tetrahydrofurans
disclosed
nelfinavir
Prior art date
Application number
DK00970988T
Other languages
Danish (da)
English (en)
Inventor
Juliette Kharsa Busse
Scott Edward Zook
Bennett Chaplin Borer
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Application granted granted Critical
Publication of DK1224177T3 publication Critical patent/DK1224177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK00970988T 1999-10-21 2000-10-19 Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner DK1224177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16069599P 1999-10-21 1999-10-21
PCT/US2000/028815 WO2001029013A1 (en) 1999-10-21 2000-10-19 Process for preparing oxazolines from tetrahydrofurans

Publications (1)

Publication Number Publication Date
DK1224177T3 true DK1224177T3 (da) 2004-05-03

Family

ID=22578030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00970988T DK1224177T3 (da) 1999-10-21 2000-10-19 Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner

Country Status (21)

Country Link
US (3) US6403799B1 (zh)
EP (1) EP1224177B1 (zh)
JP (2) JP2003512361A (zh)
KR (1) KR100706938B1 (zh)
CN (3) CN1539834A (zh)
AT (1) ATE259360T1 (zh)
AU (1) AU775783B2 (zh)
BR (1) BR0015229A (zh)
CA (1) CA2387997C (zh)
CZ (1) CZ20021361A3 (zh)
DE (1) DE60008270T2 (zh)
DK (1) DK1224177T3 (zh)
ES (1) ES2215737T3 (zh)
HK (2) HK1051365A1 (zh)
HU (1) HUP0203214A3 (zh)
IL (1) IL149197A0 (zh)
PL (1) PL364878A1 (zh)
PT (1) PT1224177E (zh)
RU (1) RU2242468C2 (zh)
SI (1) SI1224177T1 (zh)
WO (1) WO2001029013A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014011900A2 (en) 2012-07-11 2014-01-16 Blueprint Medicines Inhibitors of the fibroblast growth factor receptor
EP3060560A1 (en) 2013-10-25 2016-08-31 Blueprint Medicines Corporation Inhibitors of the fibroblast growth factor receptor
WO2015108992A1 (en) 2014-01-15 2015-07-23 Blueprint Medicines Corporation Heterobicyclic compounds and their use as fgfr4 receptor inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
AU6087194A (en) 1993-01-15 1994-08-15 Agouron Pharmaceuticals, Inc. Hiv protease inhibitors
TW270118B (zh) 1993-02-26 1996-02-11 Schering Corp
US5527829A (en) 1994-05-23 1996-06-18 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
EP0983999B8 (en) 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
EP0984000B1 (en) 1995-09-26 2008-12-03 Japan Tabacco Inc. Process for producing amide derivatives and intermediate compounds
US5925759A (en) * 1996-09-05 1999-07-20 Agouron Pharmaceuticals, Inc. Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5962725A (en) * 1996-09-05 1999-10-05 Agouron Pharmaceuticals, Inc. Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US6001851A (en) * 1997-03-13 1999-12-14 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
SI1224177T1 (en) 2004-06-30
CN1162408C (zh) 2004-08-18
CN1539832A (zh) 2004-10-27
HUP0203214A2 (hu) 2003-01-28
EP1224177B1 (en) 2004-02-11
ATE259360T1 (de) 2004-02-15
ES2215737T3 (es) 2004-10-16
US20030023092A1 (en) 2003-01-30
JP2008007522A (ja) 2008-01-17
US6403799B1 (en) 2002-06-11
US20020038033A1 (en) 2002-03-28
BR0015229A (pt) 2002-07-23
PT1224177E (pt) 2004-06-30
CN1266140C (zh) 2006-07-26
AU8029000A (en) 2001-04-30
KR20020047255A (ko) 2002-06-21
US6472534B2 (en) 2002-10-29
PL364878A1 (en) 2004-12-27
CN1539834A (zh) 2004-10-27
JP2003512361A (ja) 2003-04-02
CN1390210A (zh) 2003-01-08
EP1224177A1 (en) 2002-07-24
HUP0203214A3 (en) 2005-01-28
CZ20021361A3 (cs) 2003-03-12
DE60008270T2 (de) 2004-07-15
KR100706938B1 (ko) 2007-04-11
AU775783B2 (en) 2004-08-12
DE60008270D1 (de) 2004-03-18
HK1051365A1 (en) 2003-08-01
HK1068880A1 (en) 2005-05-06
RU2242468C2 (ru) 2004-12-20
CA2387997C (en) 2006-06-13
CA2387997A1 (en) 2001-04-26
WO2001029013A1 (en) 2001-04-26
IL149197A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
CA2405486A1 (fr) Procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
DK1353917T3 (da) Ny fremgangsmåde til syntesen af 5-(4-fluorphenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrol-3-carboxylsyre phenylamid
PL358887A1 (en) Process for the preparation of substituted octanoyl amides
DK0835257T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af camptothecin-derivater (CPT-11) og beslægtede forbindelser
EA200601672A1 (ru) Конъюгаты гидроксиалкилкрахмала и белка, полученные восстановительным аминированием
DE60020726D1 (de) Biaryletherderivate, die als inhibitoren der monoamin-wiederaufnahme nützlich sind
ATE423113T1 (de) Substituierte oxoazaheterozyclische verbindungen
DK1778710T3 (da) Tanaprogetderivater, -metabolitter og anvendelser deraf
ATE326454T1 (de) Neue bernsteinsäure derivative als cysteine- protease-inhibitoren
DE60218703D1 (de) (-)-1-(3,4-dichlorphenyl)-3-azabicyclo ä3.1.0ühexan, zusammensetzungen davon und verwendung als dopamin-wiederaufnahme-hemmer
DK1131318T3 (da) Fremgangsmåde til fremstilling af 5-substituerede pyrazoler under anvendelse af dithietaner
TR200302268T4 (tr) NOS inhibitörleri olarak yararlı N-heterosiklik türevler.
DE60130771D1 (de) Substituierte heterocyclische amide
DK1255747T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-on
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
DK1224177T3 (da) Fremgangsmåde til fremstilling af oxazoliner fra tetrahydrofuraner
NO20071253L (no) Fremgangsmate for syntese av C-2, C-3 substituerte N-alkylerte indoler anvendbare som CPLA2-inhibitorer.
DK1246813T3 (da) Fremgangsmåde til fremstilling af Citalopram
DK1102765T3 (da) Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
DK1089976T3 (da) Fremgangsmåde til fremstilling af 5-bromisoquinolin og dets 8-nitroderivat
YU30202A (sh) Postupak za dobijanje oksazolina iz tetrahidrofurana
NO20041573L (no) Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme
DK0998470T3 (da) Fremgangsmåde til fremstilling af aminderivater af alkyloxyfuranon, forbindelser fremstillet ved denne fremgangsmåde og anvendelse af disse forbindelser
BRPI0514313A (pt) processo para sintetizar um composto, e, composto
DK1250335T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner